Vertex Reports First-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Vertex Pharma (VRTX) Tops Q1 EPS by 14c; Reiterates Outlook
April 26, 2018 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $0.76, $0.14 better than the analyst estimate of $0.62. Revenue for the quarter came in at $638 million versus the consensus estimate of $617.59 million.
Company reiterates full-year 2018 total CF product revenue guidance of $2.65 to $2.80 billion and combined... More
